FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Otis Brawley

Research Profile

Disorders

Geographic Areas

United States

Living Beings

Procedures

Chemicals & Drugs

Concepts & Ideas

Organizations

American Cancer Society

Activities & Behaviors

SEER Program

Co-author Network

Publications

TOP 3
Robert A Smith; Durado Brooks; Vilma Cokkinides; Debbie Saslow; Otis W Brawley
Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.
Richard C Wender; Andrew M D Wolf; G Scott Gazelle; Daniel C Sullivan; William Travis; Louise Walter; Ermilo Barrera; Otis W Brawley; Timothy R Church; Graham A Colditz; David S Ettinger; Ruth Etzioni; Christopher R Flowers; Elizabeth T H Fontham; Douglas K Kelsey; Samuel J LaMonte; James S Michaelson; Kevin C Oeffinger; Ya-Chen Tina Shih; Robert A Smith
American Cancer Society lung cancer screening guidelines.
Christopher R Flowers; Leon Bernal-Mizrachi; Uma Borate; Otis W Brawley; Kevin Bumpers; Will Donnellan; Tanyanika Douglas-Holland; Rajinder S Grover; David L Jaye; Nassoma King; Jeanne Kowalski; Mary Jo Lechowicz; Joseph Lipscomb; Vishnu Reddy; Pareen J Shenoy; Rajni Sinha; Angelina The; James Foran
Examining racial differences in diffuse large B-cell lymphoma presentation and survival.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Otis Brawley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Robert A Smith; Durado Brooks; Vilma Cokkinides; Debbie Saslow; Otis W Brawley
Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.
CA: a cancer journal for clinicians 2013;63(2):88-105.
2013: Richard C Wender; Andrew M D Wolf; G Scott Gazelle; Daniel C Sullivan; William Travis; Louise Walter; Ermilo Barrera; Otis W Brawley; Timothy R Church; Graham A Colditz; David S Ettinger; Ruth Etzioni; Christopher R Flowers; Elizabeth T H Fontham; Douglas K Kelsey; Samuel J LaMonte; James S Michaelson; Kevin C Oeffinger; Ya-Chen Tina Shih; Robert A Smith
American Cancer Society lung cancer screening guidelines.
CA: a cancer journal for clinicians 2013;63(2):107-17.
2013: Christopher R Flowers; Leon Bernal-Mizrachi; Uma Borate; Otis W Brawley; Kevin Bumpers; Will Donnellan; Tanyanika Douglas-Holland; Rajinder S Grover; David L Jaye; Nassoma King; Jeanne Kowalski; Mary Jo Lechowicz; Joseph Lipscomb; Vishnu Reddy; Pareen J Shenoy; Rajni Sinha; Angelina The; James Foran
Examining racial differences in diffuse large B-cell lymphoma presentation and survival.
Leukemia & lymphoma 2013;54(2):268-76.
2013: Derick Okwan-Duodu; Guillermo E Umpierrez; Otis W Brawley; Roberto Diaz
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages.
American journal of cancer research 2013;3(1):21-33.
2013: Otis W Brawley
A brief history of the American Cancer Society Extramural Research Program.
CA: a cancer journal for clinicians 2013;63(1):9-10.
2012: Otis W Brawley
Trends in prostate cancer in the United States.
Journal of the National Cancer Institute. Monographs 2012;2012(45):152-6.
2012: Reshma Jagsi; Theodore S Lawrence; Colleen A Lawton; Quynh-Thu Le; Jeff M Michalski; Benjamin Movsas; Charles R Thomas; Justin E Bekelman; Otis W Brawley; Joseph O Deasy; Stephen M Hahn
A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment.
International journal of radiation oncology, biology, physics 2012;84(2):318-22.
2012: Christopher R Flowers; Joseph Lipscomb Jr; Loretta J Nastoupil; Otis W Brawley; Amy Y Chen; Stacey A Fedewa; Elizabeth M Ward
Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(9):1520-30.
2012: Otis W Brawley
Prostate cancer screening: what we know, don't know, and believe.
Annals of internal medicine 2012;157(2):135-6.
2012: Peter B Bach; Donald A Berry; Otis W Brawley; Tim Byers; GRaham Colditz; Christopher G Azzoli; Michael K Gould; James R Jett; Joshua N Mirkin; Thomas K Oliver; Amir Qaseem; Anita L Sabichi; Rebecca Smith-Bindman; Douglas E Wood; Frank C Detterbeck
Benefits and harms of CT screening for lung cancer: a systematic review.
JAMA : the journal of the American Medical Association 2012;307(22):2418-29.
2012: Otis W Brawley
Epilogue.
Journal of the National Cancer Institute. Monographs 2012;2012(44):134.
2012: Otis W Brawley
Risk-based mammography screening: an effort to maximize the benefits and minimize the harms.
Annals of internal medicine 2012;156(9):662-3.
2012: Otis W Brawley
Prostate cancer epidemiology in the United States.
World journal of urology 2012;30(2):195-200.
2012: Timothy V Johnson; Otis W Brawley; Steven J Garlow; Viraj A Master
Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology.
Psycho-oncology 2012;21(4):351-6.
2011: Diane E Meier; Otis W Brawley
Palliative care and the quality of life.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(20):2750-2.
2011: Rebecca Siegel; Elizabeth Ward; Otis W Brawley; Ahmedin Jemal
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.
CA: a cancer journal for clinicians 2011;61(4):212-36.
2011: Otis W Brawley
Avoidable cancer deaths globally.
CA: a cancer journal for clinicians 2011;61(2):67-8.
2011: Robert Smith; Vilma Cokkinides; Durado Brooks; Debbie Saslow; Mona Shah; Otis W Brawley
Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening.
CA: a cancer journal for clinicians 2011;61(1):8-30.
2011: Gerald L Andriole; David Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L J Tammela; Claudio Teloken; Donald Tindall; Stephen J Freedland; Matthew C Somerville; Timothy H Wilson; Ivy Fowler; Ramiro Castro; Roger S Rittmaster
The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study.
The Journal of urology 2011;185(1):126-31.
2010: Otis W Brawley
Toward a better understanding of race and cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(24):5920-2.
2010: Otis W Brawley; Katherine S Virgo
From the guest editors: introduction for the impact of health care reform on cancer patients.
Cancer journal (Sudbury, Mass.) 2010;16(6):551-3.
2010: Timothy V Johnson; Wayland Hsiao; Keith A Delman; Ashesh B Jani; Otis W Brawley; Viraj A Master
Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: results from the Surveillance, Epidemiology, and End Results program.
Cancer 2010;116(12):2960-6.
2010: Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Effect of dutasteride on the risk of prostate cancer.
The New England journal of medicine 2010;362(13):1192-202.
2010: Robert Smith; Vilma Cokkinides; Durado Brooks; Debbie Saslow; Otis W Brawley
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.
CA: a cancer journal for clinicians 2010;60(2):99-119.
2010: Otis W Brawley; Ted Gansler
Introducing the 2010 American Cancer Society prostate cancer screening guideline.
CA: a cancer journal for clinicians 2010;60(2):68-9.
2010: Jamillah Berry; Lee S Caplan; Sharon K. Davis; Patrick Minor; Margaret Counts-Spriggs; Roni Glover; Vickie Ogunlade; Kevin Bumpers; John Kauh; Otis W Brawley; Christopher Flowers
A black-white comparison of the quality of stage-specific colon cancer treatment.
Cancer 2010;116(3):713-22.
2010: Thomas Glynn; John R Seffrin; Otis W Brawley; Nathan Grey; Hana Ross
The globalization of tobacco use: 21 challenges for the 21st century.
CA: a cancer journal for clinicians 2010;60(1):50-61.
2010: Louise J Short; Maxine D Fisher; Peter M Wahl; Monique B Kelly; Grant D Lawless; Sandra White; Nancy A Rodriguez; Vincent J Willey; Otis W Brawley
Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention.
Cancer 2010;116(1):193-202.
2009: Otis W Brawley
Information over exaggeration.
U.S. news & world report 2009;146(11):24.
2009: Otis W Brawley
Prostate cancer screening; is this a teachable moment?
Journal of the National Cancer Institute 2009;101(19):1295-7.
2009: Otis W Brawley; Daniel E Smith; Rebecca A Kirch
Taking action to ease suffering: advancing cancer pain control as a health care priority.
CA: a cancer journal for clinicians 2009;59(5):285-9.
2009: Otis W Brawley
Oropharyngeal cancer, race, and the human papillomavirus.
Cancer prevention research (Philadelphia, Pa.) 2009;2(9):769-72.
2009: Otis W Brawley
Is race really a negative prognostic factor for cancer?
Journal of the National Cancer Institute 2009;101(14):970-1.
2009: Otis W Brawley; Donna P Ankerst; Ian M Thompson
Screening for prostate cancer.
CA: a cancer journal for clinicians 2009;59(4):264-73.
2009: Peter Boyle; Otis W Brawley
Prostate cancer: current evidence weighs against population screening.
CA: a cancer journal for clinicians 2009;59(4):220-4.
2009: Monica Rizzo; Mary Jo Lund; Marina Mosunjac; Harvey L Bumpers; Leslie Holmes; Ruth O' REGAN; Otis W Brawley; Sheryl Gabram-Mendola
Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer.
Cancer 2009;115(13):3009-15.
2009: Elizabeth Goss; Ana Maria Lopez; Carol L Brown; Dana S Wollins; Otis W Brawley; Derek Raghavan
American society of clinical oncology policy statement: disparities in cancer care.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2881-5.
2009: Robert Smith; Vilma Cokkinides; Otis W Brawley
Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.
CA: a cancer journal for clinicians 2009;59(1):27-41.
2009: Mary Jo Lund; Katrina F Trivers; Peggy L Porter; Ralph J Coates; Brian Leyland-Jones; Otis W Brawley; Elaine W Flagg; Ruth O' REGAN; Sheryl Gabram-Mendola; John Eley
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
Breast cancer research and treatment 2009;113(2):357-70.
2008: Otis W Brawley
New ACS chief medical officer. Interview by Carrie Printz.
Cancer 2008;113(7):1499.
2008: Otis W Brawley; Mitchell Z Berger
Cancer and disparities in health: perspectives on health statistics and research questions.
Cancer 2008;113(7 Suppl):1744-54.
2008: Ashesh B Jani; Peter A S Johnstone; Stanley L Liauw; Viraj A Master; Otis W Brawley
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
American journal of clinical oncology 2008;31(4):375-8.
2008: Sheryl Gabram-Mendola; Mary Jo B Lund; Jessica Gardner; Nadjo Hatchett; Harvey L Bumpers; Joel A. Okoli; Monica Rizzo; Barbara J Johnson; Gina B Kirkpatrick; Otis W Brawley
Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population.
Cancer 2008;113(3):602-7.
2008: Mary Jo B Lund; Ebonee N Butler; Harvey L Bumpers; Joel A. Okoli; Monica Rizzo; Nadjo Hatchett; Victoria L Green; Otis W Brawley; Gabriela M Oprea-Ilies; Sheryl Gabram-Mendola
High prevalence of triple-negative tumors in an urban cancer center.
Cancer 2008;113(3):608-15.
2008: Otis W Brawley; Llewellyn J Cornelius; Linda R Edwards; Vanessa Northington Gamble; Bettye L Green; Charles Inturrisi; Andra H James; Danielle Laraque; Magda Mendez; Carolyn J Montoya; Bradley Pollock; Lawrence Robinson; Aaron P Scholnik; Melissa Schori
National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.
Annals of internal medicine 2008;148(12):932-8.
2008: Otis W Brawley; Llewellyn J Cornelius; Linda R Edwards; Vanessa Northington Gamble; Bettye L Green; Charles E Inturrisi; Andra H James; Danielle Laraque; Magda H Mendez; Carolyn J Montoya; Bradley Pollock; Lawrence Robinson; Aaron P Scholnik; Melissa Schori
NIH consensus development statement on hydroxyurea treatment for sickle cell disease.
NIH consensus and state-of-the-science statements 2008;25(1):1-30.
2008: Gabriel P Haas; Nicolas Delongchamps; Otis W Brawley; Ching Y Wang; Gustavo de la Roza
The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.
The Canadian journal of urology 2008;15(1):3866-71.
2007: Otis W Brawley; Ashesh B Jani; Viraj A Master
Prostate cancer and race.
Current problems in cancer 2007;31(3):211-25.
2007: Mitchel Berger; Mary Jo Lund; Otis W Brawley
Racial disparities in lung cancer.
Current problems in cancer 2007;31(3):202-10.
2007: Christopher Flowers; Roni Glover; Sagar Lonial; Otis W Brawley
Racial differences in the incidence and outcomes for patients with hematological malignancies.
Current problems in cancer 2007;31(3):182-201.
2007: John Kauh; Otis W Brawley; Mitchell Berger
Racial disparities in colorectal cancer.
Current problems in cancer 2007;31(3):123-33.
2007: Otis W Brawley; Ashesh B Jani
Race and disparities in health.
Current problems in cancer 2007;31(3):114-22.
2006: Colin B Begg; Otis W Brawley; Robert M Califf; David L DeMets; Susan S Ellenberg; Richard S. Kaplan
Marketing drugs too early in testing.
Science (New York, N.Y.) 2006;312(5771):195.
2006: David Wendler; Raynard S Kington; Jennifer Madans; Gretchen Van Wye; Heidi Christ-Schmidt; Laura A Pratt; Otis W Brawley; Cary P Gross; Ezekiel J Emanuel
Are racial and ethnic minorities less willing to participate in health research?
PLoS medicine 2006;3(2):e19.
2006: Otis W Brawley
Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):332-3.
2005: Shamim M Baker; Otis W Brawley; Leonard S Marks
Effects of untreated syphilis in the negro male, 1932 to 1972: a closure comes to the Tuskegee study, 2004.
Urology 2005;65(6):1259-62.
2005: Otis W Brawley; Barnett S Kramer
Cancer screening in theory and in practice.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(2):293-300.
2004: Gerald L Andriole; David Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Donald Tindall; Sharon Breed; Matt Somerville; Roger S Rittmaster
Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial.
The Journal of urology 2004;172(4 Pt 1):1314-7.
2004: Vasileios Assikis; Otis W Brawley
Chemoprevention in prostate cancer.
Current problems in cancer 2004;28(4):218-30.
2004: Otis W Brawley
Prostate cancer screening: clinical applications and challenges.
Urologic oncology 2004;22(4):353-7.
2004: Otis W Brawley
The study of accrual to clinical trials: can we learn from studying who enters our studies?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2039-40.
2004: Otis W Brawley
Cancer screening.
Seminars in oncology 2004;31(2 Suppl 4):47-53.
2003: Otis W Brawley
Nonmedical factors in treatment selection.
The Urologic clinics of North America 2003;30(2):331-5.
2003: Michael Benjamin; Sreekanth Reddy; Otis W Brawley
Myeloma and race: a review of the literature.
Cancer metastasis reviews 2003;22(1):87-93.
2003: Sreekanth Reddy; Marc Shapiro; Ronald Morton; Otis W Brawley
Prostate cancer in black and white Americans.
Cancer metastasis reviews 2003;22(1):83-6.
2003: William F Anderson; Asad Umar; Otis W Brawley
Colorectal carcinoma in black and white race.
Cancer metastasis reviews 2003;22(1):67-82.
2003: Otis W Brawley
Population categorization and cancer statistics.
Cancer metastasis reviews 2003;22(1):11-9.
2003: Otis W Brawley
Introduction: Cancer and health disparities.
Cancer metastasis reviews 2003;22(1):7-9.
2003: Michael Hamilton; William Dahut; Otis W Brawley; Patricia Davis; Toni Wells-Jones; David R Kohler; Paul H Duray; David J Liewehr; Nehal J Lakhani; Seth M Steinberg; William D Figg; Eddie Reed
A phase I/II study of high-dose tamoxifen in combination with vinblastine in patients with androgen-independent prostate cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(3):195-201.
2003: Ian M Thompson; Joseph W Basler; Robin J Leach; Dean A Troyer; Eric Klein; Otis W Brawley
Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer.
Urologic oncology 2003;21(1):73-8.
2003: Otis W Brawley
Hormonal prevention of prostate cancer.
Urologic oncology 2003;21(1):67-72.
2003: Otis W Brawley
Informed consent for prostate-specific antigen-based screening.
Urology 2003;61(1):10-2.
2003: Lovell Jones; Otis W Brawley; Marian Johnson-Thompson; Ngina Lythcott; Lisa A Newman
Overview of the summit meeting evaluating research in African-American women.
Cancer 2003;97(1 Suppl):207-10.
2002: Otis W Brawley
Some perspective on black-white cancer statistics.
CA: a cancer journal for clinicians 2002;52(6):322-5.
2002: William F Anderson; Nilanjan Chatterjee; William B. Ershler; Otis W Brawley
Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.
Breast cancer research and treatment 2002;76(1):27-36.
2002: William F Anderson; Otis W Brawley; Shine Chang
Oophorectomy in carriers of BRCA mutations.
The New England journal of medicine 2002;347(13):1037-40; author reply 1037-40.
2002: Peter B Bach; Deborah Schrag; Otis W Brawley; Aaron Galaznik; Sofia Yakren; Colin B Begg
Survival of blacks and whites after a cancer diagnosis.
JAMA : the journal of the American Medical Association 2002;287(16):2106-13.
2002: Warren B Sateren; Edward L Trimble; Jeffrey Abrams; Otis W Brawley; Nancy Breen; Leslie Ford; Mary McCabe; Richard S. Kaplan; Malcolm Smith; Richard Ungerleider; Michaele C Christian
How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2109-17.
2002: Otis W Brawley
Disaggregating the effects of race and poverty on breast cancer outcomes.
Journal of the National Cancer Institute 2002;94(7):471-3.
2002: Otis W Brawley
The potential for prostate cancer chemoprevention.
Reviews in urology 2002;4 Suppl 5():S11-7.
2001: Otis W Brawley; S Barnes; Howard L Parnes
The future of prostate cancer prevention.
Annals of the New York Academy of Sciences 2001;952():145-52.
2001: Kenneth C Chu; William F Anderson; A Fritz; L A Ries; Otis W Brawley
Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups.
Cancer 2001;92(1):37-45.
2001: Otis W Brawley; S T Barnes
Potential agents for prostate cancer chemoprevention.
Epidemiologic reviews 2001;23(1):168-72.
2001: William F Anderson; Kenneth C Chu; N Chatterjee; Otis W Brawley; L A Brinton
Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):18-27.
2000: Barnett S Kramer; Otis W Brawley
Cancer screening.
Hematology/oncology clinics of North America 2000;14(4):831-48.
2000: Otis W Brawley; Howard L Parnes
Prostate cancer prevention trials in the USA.
European journal of cancer (Oxford, England : 1990) 2000;36(10):1312-5.
2000: Robert E Tarone; Kenneth C Chu; Otis W Brawley
Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.
Epidemiology (Cambridge, Mass.) 2000;11(2):167-70.
2000: George A Alexander; Otis W Brawley
Association of Helicobacter pylori infection with gastric cancer.
Military medicine 2000;165(1):21-7.
1999: Kenneth C Chu; Robert E Tarone; Otis W Brawley
Breast cancer trends of black women compared with white women.
Archives of family medicine 1999;8(6):521-8.
1999: Raymond C Bergan; Eddie Reed; Charles E Myers; Donna Headlee; Otis W Brawley; H K Cho; William D Figg; AC Tompkins; W Marston Linehan; David R Kohler; Seth M Steinberg; Mikhail V Blagosklonny
A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2366-73.
1998: Otis W Brawley; N Figueroa-Valles
Prostate cancer research and the National Cancer Institute.
Seminars in urologic oncology 1998;16(4):235-40.
1998: George A Alexander; Otis W Brawley
Prostate cancer treatment outcome in blacks and whites: a summary of the literature.
Seminars in urologic oncology 1998;16(4):232-4.
1998: Otis W Brawley; Kevin B Knopf; Ian M Thompson
The epidemiology of prostate cancer part II: the risk factors.
Seminars in urologic oncology 1998;16(4):193-201.
1998: Otis W Brawley; Kevin B Knopf; R Merrill
The epidemiology of prostate cancer part I: descriptive epidemiology.
Seminars in urologic oncology 1998;16(4):187-92.
1998: Otis W Brawley
Prostate cancer and black men.
Seminars in urologic oncology 1998;16(4):184-6.
1998: Nancy A Dawson; William D Figg; Otis W Brawley; Raymond C Bergan; MR Cooper; Adrian M Senderowicz; Donna Headlee; Seth M Steinberg; M Sutherland; Nicholas Patronas; Edward A Sausville; W Marston Linehan; Eddie Reed; Oliver Sartor
Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(1):37-44.
1998: Otis W Brawley
The study of untreated syphilis in the negro male.
International journal of radiation oncology, biology, physics 1998;40(1):5-8.
1997: Otis W Brawley
Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.
Cancer 1997;80(9):1857-63.
1997: R M Merrill; Otis W Brawley
Prostate cancer incidence and mortality rates among white and black men.
Epidemiology (Cambridge, Mass.) 1997;8(2):126-31.
1996: H A Tejeda; S B Green; Edward L Trimble; L Ford; J L High; R S Ungerleider; M A Friedman; Otis W Brawley
Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.
Journal of the National Cancer Institute 1996;88(12):812-6.
1996: Otis W Brawley; Bruce D Cheson; P H Phillips
Clinical trials referral resource. Cancer chemoprevention and control trials.
Oncology (Williston Park, N.Y.) 1996;10(4):499-500.
1996: Otis W Brawley; P H Phillips; Bruce D Cheson
Cancer chemoprevention trials.
Oncology (Williston Park, N.Y.) 1996;10(3):324-7.
1996: William D Figg; Nancy A Dawson; M N Middleman; Otis W Brawley; Richard M Lush; Adrian M Senderowicz; S H Steinberg; AC Tompkins; Eddie Reed; Oliver Sartor
Flutamide withdrawal and concomitant initiation of aminoglutethimide in patients with hormone refractory prostate cancer.
Acta oncologica (Stockholm, Sweden) 1996;35(6):763-5.
1996: Otis W Brawley; Bruce D Cheson; P H Phillips
Clinical trials referral resource. Breast cancer and prostate cancer.
Oncology (Williston Park, N.Y.) 1996;10(1):100, 102.
1995: Gleen J Gormley; Otis W Brawley; Ian M Thompson
The potential application of finasteride for chemoprevention of prostate cancer.
Annals of the New York Academy of Sciences 1995;768():163-9.
1995: P Feigl; B Blumenstein; Ian M Thompson; J Crowley; M Wolf; B S Kramer; C A Coltman; Otis W Brawley; Leslie G Ford
Design of the Prostate Cancer Prevention Trial (PCPT).
Controlled clinical trials 1995;16(3):150-63.
1995: Otis W Brawley; H Tejeda
Minority inclusion in clinical trials issues and potential strategies.
Journal of the National Cancer Institute. Monographs 1995;(17):55-7.
1995: Linda C Harlan; Otis W Brawley; F Pommerenke; P Wali; B Kramer
Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):93-100.
1994: Leslie G Ford; Otis W Brawley; J A Perlman; S G Nayfield; K A Johnson; B S Kramer
The potential for hormonal prevention trials.
Cancer 1994;74(9 Suppl):2726-33.
1994: Otis W Brawley; Leslie G Ford; Ian M Thompson; J A Perlman; B S Kramer
5-Alpha-reductase inhibition and prostate cancer prevention.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(2):177-82.
1994: Eric J Feuer; C M Frey; Otis W Brawley; S G Nayfield; J B Cunningham; N L Geller; George J Bosl; B S Kramer
After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):368-77.
1994: Robert Yarchoan; J A Lietzau; B Y Nguyen; Otis W Brawley; James M Pluda; MW Saville; Kathleen M Wyvill; Seth M Steinberg; Riad Agbaria; Hiroaki Mitsuya
A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection.
The Journal of infectious diseases 1994;169(1):9-17.
1993: Arnold D Kaluzny; Otis W Brawley; D Garson-Angert; J Shaw; Paul A Godley; Richard B Warnecke; L Ford
Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
Journal of the National Cancer Institute 1993;85(23):1945-50.
1993: B Y Nguyen; L E Shay; Kathleen M Wyvill; James M Pluda; Otis W Brawley; R B Cohen; Scott M Whitcup; D J Venzon; S Broder; Robert Yarchoan
A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
The Journal of infectious diseases 1993;168(4):810-7.
1993: J A Perlman; Otis W Brawley; Leslie G Ford; B S Kramer
Vasectomy and increased risk of prostate cancer.
JAMA : the journal of the American Medical Association 1993;270(6):706-7.
1993: K A Johnson; Otis W Brawley; J A Perlman; Leslie G Ford
Re: Chemoprevention studies in the community clinical oncology program.
Journal of the National Cancer Institute 1993;85(10):832-3.
1991: Eddie Reed; J Jacob; Otis W Brawley
Measures of renal function in patients with cisplatin-related chronic renal disease.
Journal of the National Medical Association 1991;83(6):522-6.